Home / Import refusals / AEK-3072039-3/11/1

FDA Import Refusal AEK-3072039-3/11/1 — AbbVie Deutschland GmbH & Co. KG

AbbVie Deutschland GmbH & Co. KG — FEI 3002807401

The FDA refused shipment AEK-3072039-3/11/1 from AbbVie Deutschland GmbH & Co. KG (Germany) on March 31, 2023. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 31, 2023
Country
Germany
Product Category
Drugs and Biologics
Product Code
61YCY02 ADALIMUMAB
Charges
75

Recent inspections

  • 1272781 (NAI Fri May 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1274472 (VAI Thu Sep 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100574 (NAI Fri Jul 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 900873 (NAI Thu Sep 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 806316 (VAI Thu Oct 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-7596909-1/10002/1 (Fri Jan 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2349069-5/10002/1 (Wed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1228922-3/10002/1 (Tue Dec 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8539945-7/12/1 (Wed Jun 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4643769-7/11/1 (Wed Jan 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources